Providing formulation solutions for your most challenging drug candidates
Tyndall Formulation Services, LLC is a contract research organization that specializes in developing novel polymer excipients for drug delivery applications. We leverage our expertise in polymer science to formulate challenging drug candidates. Formulation solutions include nanoparticle formulations, primarily formulated for parenteral applications.
Laboratory Scale Synthesis
Novel Excipient Development
Formulation Technology Transfer
3802 Spectrum Blvd.
Tampa, FL 33612
Kevin Sill, Ph.D. is a recognized expert in the field of nanoparticles and drug delivery, founded Tyndall Formulation Services. Dr. Sill completed his Ph.D. and M.S. in polymer science and engineering at the University of Massachusetts and holds a B.S. degree in chemistry from the University of Illinois. He is a co-inventor on 27 issued US patents as well as 61 additional international patents and has authored or co-authored 23 peer-reviewed publications in fields spanning polymer chemistry, polymer physics, nanoparticles, and drug delivery applications.